Market Research Logo

Finland Pharmaceuticals and Healthcare Report Q3 2015


Attention: There is an updated edition available for this report.

BMI View: Finland's growing and ageing population will drive pharmaceutical demand. Despite beingrelatively small in size compared to some of its Western European counterparts, the market is boosted byhigh GDP per-capita, ensuring continued spending on high-value drugs in the medium-term. However,rising healthcare costs will place a heavy burden on government finances, requiring patented drug makersto prove the cost-effectiveness of their medicines over less expensive generic drugs.

Headline Expenditure Projections

Pharmaceuticals: EUR3.04bn (USD4.08bn) in 2014 to EUR3.10bn (USD3.41bn) in 2015;+1.9% inlocal currency terms and -16.4% in US dollar terms. Forecast in line with last quarter.

Healthcare: EUR18.88bn (USD25.30bn) in 2014 to EUR19.63bn (USD21.59bn) in 2015; +4% in localcurrency terms and -14.7% in US dollar terms. Forecast revised upwards from last quarter.


BMI Industry View
SWOT
Political
Economic
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Finland 2011-2019)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Finland 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Finland 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Finland 2011-2019)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Finland 2011-2019)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Finland 2011-2019)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Finland 2011-2019)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Finland 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Finland 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Finland 2013-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
Table: GDP By Expenditure (Finland 2012-2019)
Industry Risk Reward Index
Western Europe Risk/Reward Index
Finland Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Industry Trends And Developments
Epidemiology
Health Insurance
Table: Healthcare Resources (Finland 2009-2014)
Table: Healthcare Personnel (Finland 2009-2014)
Table: Healthcare Activity (Finland 2009-2014)
Research & Development
Clinical Trials
Regulatory Development
Pricing & Reimbursement
Intellectual Property
Competitive Landscape
Table: PIF Members
Company Developments
Demographic Forecast
Table: Population Headline Indicators (Finland 1990-2025)
Table: Key Population Ratios (Finland 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Finland 1990-2025)
Table: Population By Age Group (Finland 1990-2025)
Table: Population By Age Group % (Finland 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report